NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

In looking through the new SOS publication, I believe that what he's saying is well reasoned, but I have no idea if the company is in agreement with him on the way the treatment will be priced. I suspect that if it's treated like most therapeutics are around the world, here in the U.S. we'll pay more than elsewhere, most major industrial nations will pay about the same, but somewhat less than the U.S. and much of the rest of the world will pay substantially less.

I'm not concerned about who pays what, in the end it will be a blockbuster product on GBM alone, and as it expands into other solid cancer forms double and even triple digit billions annually could easily come into play.

I can't say whether Smith has any actual information that isn't available to the rest of us, but he's definitely knowledgeable about what's going on and I think his views are worthy of respect.

Gary